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Background
Generally speaking, neurodegenerative diseases involve 
the degradation, and death, of neurons. Since the first 
description of a transgenic Drosophila model of a human 
degenerative disease in 1998, the use of fly models has 
grown rapidly. Diseases modeled include dominant 
polyglutamine-repeat diseases, tauopathies, Alzheimer’s 
disease (AD), Parkinson’s disease (PD), and expanded 
triplet-repeat diseases in noncoding DNA. (Marsh & 
Thompson, 2006) By taking advantage of flies’ 
predisposition to climb, or negative geotaxis, locomotive 
defects can be measured and quantified over time. Using 
mutant Drosophila models allows genes of therapeutic 
interest to be identified as the mechanism of the climbing 
defect is discovered.
Abstract
As global populations continue to age, the prevalence of 
neurodegenerative disorders, such as Alzheimer’s and 
Parkinson’s disease, will continue to increase. A late onset 
symptom of neurodegenerative disease is locomotive defects. 
While many genes have been identified through whole exome 
sequencing as playing a role in human locomotion, little is 
known about what role they play in normal function. 
Dependable assays are needed to better understand the 
functions of these genes. However, modeling these diseases 
in vitro, to better understand, treat, and prevent them, has 
proven to have limitations. The isolated reality of cultures 
prevents an accurate simulation of the responses that would 
take place in the organism, such as physiological pathways 
and responses and non-autonomous cellular influences. 
Additionally, while mammalian models are important, they also 
can be prohibitive due to related costs and the length of time 
required. Fortunately, many of the issues these frameworks 
present have a small, but powerful answer: Drosophila
melanogaster. Flies are easily genetically manipulated, allow 
for pathological observation, are inexpensive to care for, have 
short lifespans of about 40 days, and have an ortholog for 
approximately 75% of human genes known to cause disease. 
(Marsh, 2006)
Through the use of the GAL4-UAS system, flies can be 
“humanized” with a gene known to affect the brain. (Marsh, 
2006). The genes will be fully characterized using behavioral 
and cellular assays. By observing the behavioral phenotypes 
of these mutants, as they age, with a negative geotaxis 
(climbing) assay, genetic targets of therapeutic interest can be 
identified. (Madabattula, 2015)
Methods
 Obtain flies for blind mutant screen
 Obtain flies with known genetic mutations
 Rear flies to obtain correct genotype for assay
 Collect flies of correct genotype, sex, and age
 Setup climbing assay
oTransfer flies into climbing tube and seal with barrier
oSetup camera focused 10 cm from the bottom
oBegin recording
oGently tap tube on foam pad to displace flies to bottom
oConduct each trial for 2 minutes from last tap
oWith fresh tube, repeat 10 times for each genotype
 Average numbers of flies per trial to pass 10 cm
 Analyze the videos by recording the total number of flies that pass the target line
 Analyze performance using statistical analysis, such as student t-test and ANOVA
 Add candidate genes to list for further characterization
Experiments Proposed
The experiments proposed include both a forward and reverse genetic screen, using 
both unknown mutants and known neurodegenerative mutants, respectively, to search 
for locomotory defects. The trial results will be compared to wild type and known 
locomotory-defective mutants. We will perform statistical analysis, using students t-test 
and ANOVA methods. We will also look for reduced lifespan in forward screened 
mutants, and this will be assessed separately. Once data is collected, we will further 
characterize these genes in our Drosophila model of neurodegeneration. We hope to 
uncover a novel gene involved in neurodegeneration with our project.
Predicted Results
We anticipate the forward genetic screen will 
result in a collection of neurodegenerative 
mutants. Our reverse genetic screen will confirm 
previous hypotheses as to the nature of the 
mutation and its effects on behavior. We will 
further analyze general behavior, including 
mating, socializing, feeding, and lifespan, of all of 
these mutants. Our long-term goal is to 
characterize these genes in working models of 
physiology and morphology associated with 
neurodegeneration, and ultimately to provide 
therapeutic insights for mammalian models of 
brain diseases.
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Figure 1.
Experimental 
setup for climbing 
assays
Figure 2. Schematic representation of genetic tools used in 
these experiments
Figure 3. Predicted results: a decrease in 
climbing ability due to the mutation of a gene 
putatively involved in neurodegeneration
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